These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27917340)

  • 1. Serum miR-95-3p is a diagnostic and prognostic marker for osteosarcoma.
    Niu J; Sun Y; Guo Q; Niu D; Liu B
    Springerplus; 2016; 5(1):1947. PubMed ID: 27917340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum miR-34a is a potential diagnostic and prognostic marker for osteosarcoma.
    Wang T; Wu J; Liu X; Li S
    Int J Clin Exp Pathol; 2017; 10(9):9683-9689. PubMed ID: 31966849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
    Li Q; Song S; Ni G; Li Y; Wang X
    Cancer Biomark; 2018 Feb; 21(3):521-526. PubMed ID: 29103020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of miR-490-3p in osteosarcoma and its clinical significance.
    Tang B; Liu C; Zhang QM; Ni M
    Eur Rev Med Pharmacol Sci; 2017 Jan; 21(2):246-251. PubMed ID: 28165565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma.
    Xu SH; Yang YL; Han SM; Wu ZH
    World J Surg Oncol; 2014 Jun; 12():195. PubMed ID: 24969351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W; Zhao ZY; Shi L; Yuan WD
    Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-429 and MiR-143-3p Function as Diagnostic and Prognostic Markers for Osteosarcoma.
    Yang L; Li H; Huang A
    Clin Lab; 2020 Oct; 66(10):. PubMed ID: 33073957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of miR-133a and miR-539 are associated with unfavorable prognosis in patients suffering from osteosarcoma.
    Mirghasemi A; Taheriazam A; Karbasy SH; Torkaman A; Shakeri M; Yahaghi E; Mokarizadeh A
    Cancer Cell Int; 2015; 15():86. PubMed ID: 26388701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum miR-195 is a diagnostic and prognostic marker for osteosarcoma.
    Cai H; Zhao H; Tang J; Wu H
    J Surg Res; 2015 Apr; 194(2):505-510. PubMed ID: 25498513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of serum miR-124 as a biomarker for diagnosis and prognosis in osteosarcoma.
    Cong C; Wang W; Tian J; Gao T; Zheng W; Zhou C
    Cancer Biomark; 2018 Feb; 21(2):449-454. PubMed ID: 29125481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
    Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T
    Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
    An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
    Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
    Yang L; Xu Q; Xie H; Gu G; Jiang J
    Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-497 as a potential serum biomarker for the diagnosis and prognosis of osteosarcoma.
    Pang PC; Shi XY; Huang WL; Sun K
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3765-3769. PubMed ID: 27735043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-21 predicts poor prognosis in patients with osteosarcoma.
    Ren X; Shen Y; Zheng S; Liu J; Jiang X
    Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of miR-330-3p: a novel independent indicator of poor prognosis in human breast cancer.
    Wang H; Chen SH; Kong P; Zhang LY; Zhang LL; Zhang NQ; Gu H
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1726-1730. PubMed ID: 29630118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
    Chen L; Chu F; Cao Y; Shao J; Wang F
    Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcoma.
    Wang NG; Wang DC; Tan BY; Wang F; Yuan ZN
    Int J Clin Exp Pathol; 2015; 8(8):9314-9. PubMed ID: 26464682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-576-3p is a novel marker correlated with poor clinical outcome in bladder cancer.
    Meng FM; Meng FM; Song XL
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):973-977. PubMed ID: 28338199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.